These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 72163)

  • 41. [The importance of determining human chorionic gonadotropin and alpha fetoproteins in the diagnosis of testicular tumor recurrence].
    Kausitz J; Bohunický L; Hupka S
    Bratisl Lek Listy; 1985 Oct; 84(4):430-5. PubMed ID: 2415223
    [No Abstract]   [Full Text] [Related]  

  • 42. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum and cellular biologic tumor markers in patients with urologic cancer.
    Javadpour N
    Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
    Harland SJ
    Br J Urol; 1992 Jun; 69(6):669. PubMed ID: 1379103
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta-human chorionic gonadotropin and alpha-fetoprotein in central and peripheral venous blood of patients with testicular tumors.
    Zenico T; Zoli M; Fiori M; Fabbri F; Tamburini C; Maltoni G
    Eur Urol; 1992; 21 Suppl 1():37-8. PubMed ID: 1385132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testicular tumour markers in spermatic vein blood.
    Light PA; Tyrrell CJ
    Br J Urol; 1987 Jan; 59(1):74-5. PubMed ID: 2435357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 48. Testicular tumors.
    Lightner DJ; Lange PH
    Immunol Ser; 1990; 53():397-401. PubMed ID: 1713066
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
    Miki T
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
    [No Abstract]   [Full Text] [Related]  

  • 50. Ferritin - another tumor marker for testicular malignancies.
    Engelmann U; Büber V; Riedmiller H; Jacobi GH
    Eur Urol; 1981; 7(6):355-8. PubMed ID: 6169531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testicular cancer: role of biological tumor markers.
    Pearson JC; Spaulding JT; Friedman MA
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract]   [Full Text] [Related]  

  • 52. Tumor markers aid therapy of testicular cancer.
    JAMA; 1979 Jul; 242(4):320-1. PubMed ID: 87526
    [No Abstract]   [Full Text] [Related]  

  • 53. Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
    Ann Intern Med; 1979 Mar; 90(3):373-85. PubMed ID: 85422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
    Lo RK; Johnson DE
    J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG; Scardino PT
    J Urol; 1980 Mar; 123(3):378-82. PubMed ID: 6153725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours.
    Newlands ES; Dent J; Kardana A; Searle F; Bagshawe KD
    Lancet; 1976 Oct; 2(7988):744-5. PubMed ID: 61427
    [No Abstract]   [Full Text] [Related]  

  • 58. False-positive markers in testicular tumours.
    Hainsworth IR; McAllister EJ; Weston R
    Lancet; 1982 Dec; 2(8311):1346. PubMed ID: 6183543
    [No Abstract]   [Full Text] [Related]  

  • 59. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
    Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
    Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
    de Bruijn HW; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Marrink J; Ockhuizen T
    Cancer; 1985 Feb; 55(4):829-35. PubMed ID: 2578303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.